View allAll Photos Tagged Create
Discussion during Plenary 2. Creating the Future: Global Opportunities for the Next Generation
L-R:
Helena Verellen - Board Member, Empowered by You; Past Vice President, International Marketing, Sony Music Entertainment
Perry Yeatman - CEO, Perry Yeatman Global Partners
Dr. Elisa Konofagou - Associate Professor, Biomedical Engineering & Radiology, Columbia University
Carolina Jannicelli - Managing Director & Head of Latin America, JPMorgan Private Bank
Womensphere Emerging Leaders Global Summit 2013
The Next Generation of Women Leaders
CREATING THE FUTURE
January 17, 2013 - Main Summit Day
Columbia University
in the City of New York
**View all of the speakers on Main Summit Day via On-Demand on FORA.TV!
VIEW HERE NOW:
fora.tv/conference/womensphere_4th_annual_emerging_leader...
*** Join in & continue the conversation:
Twitter @womensphere
Use the hashtags #EmergingLeaders and #Womensphere
Summit Website:
www.emergingleadersglobalsummit.org
Organization Website:
Photography by Meriden Villanueva (Twitter: @meridenv)
www.facebook.com/maryelizabethrobinsonphotography
It's moments like these that you just happen to capture something beautiful that makes me think that maybe this journey I'm trying to pursue isn't so crazy after all.
Created these custom figures featuring an Adult walking their Kolter Kid to school. The Adult is wearing their favorite regional college sweater.
I created this little tag (it's just 2" x 2") for a special cause my friend Tamar is putting together. You can read about it here: tarisota.typepad.com/hope/ She is putting together about 100 tags created by mixed media artists from all over the world and placing them all onto a fabulous one of a kind dress form.
For your chance to own this one of a kind art piece please go to
www.everydayhero.com.au/creating_hope and donate $5Au dollars. All money raised goes directly to the Australian Cancer Research Foundation. Each $5 donation you make will give you another chance to win.
Here is my contribution.
Created using Hero Arts CL270 - Sky's the limit, pearls, button and flower.
Thanks for looking!
Created for the Art Week Gallery theme Abstracts – whole or partial.
Created with Paint/Paint Shop Pro/DDG AI/NightCafe AI
How methane is created and destroyed on Mars is an important question in understanding the various detections and non-detections of methane at Mars, with differences in both time and location. Although making up a very small amount of the overall atmospheric inventory, methane in particular holds key clues to the planet’s current state of activity.
This graphic depicts some of the possible ways methane might be added or removed from the atmosphere.
One exciting possibility is that methane is generated by microbes. If buried underground, this gas could be stored in lattice-structured ice formations known as clathrates, and released to the atmosphere at a much later time.
Methane can also be generated by reactions between carbon dioxide and hydrogen (which, in turn, can be produced by reaction of water and olivine-rich rocks), by deep magmatic degassing or by thermal degradation of ancient organic matter. Again, this could be stored underground and outgassed through cracks in the surface. Methane can also become trapped in pockets of shallow ice, such as seasonal permafrost.
Ultraviolet radiation can both generate methane – through reactions with other molecules or organic material already on the surface, such as comet dust falling onto Mars – and break it down. Ultraviolet reactions in the upper atmosphere (above 60 km) and oxidation reactions in the lower atmosphere (below 60 km) acts to transform methane into carbon dioxide, hydrogen and water vapour, and leads to a lifetime of the molecule of about 300 years.
Methane can also be quickly distributed around the planet by atmospheric circulation, diluting its signal and making it challenging to identify individual sources. Because of the lifetime of the molecule when considering atmospheric processes, any detections today imply it has been released relatively recently.
But other generation and destruction methods have been proposed which explain more localized detections and also allow a faster removal of methane from the atmosphere, closer to the surface of the planet. Dust is abundant in the lower atmosphere below 10 km and may play a role, along with interactions directly with the surface. For example, one idea is that methane diffuses or ‘seeps’ through the surface in localized regions, and is adsorbed back into the surface regolith. Another idea is that strong winds eroding the planet’s surface allows methane to react quickly with dust grains, removing the signature of methane. Seasonal dust storms and dust devils could also accelerate this process.
Continued exploration at Mars – from orbit and the surface alike – along with laboratory experiments and simulations, will help scientists to better understand the different processes involved in generating and destroying methane.
Credits: ESA
I've been terribly negligent with my Flickr account, so I'm finally getting caught up on uploading some of my favorites from the last year+!
left wrist
5-9-08
"create."
i'm a writer, i do mixed media art, i take photos, i make jewelry..
one of the most important things in my life is creating.
this is my daily reminder.
Created for Monday Music Mania:
PROCOL HARUM - A Whiter Shade of Pale
PROCOL HARUM - A Whiter Shade of Pale
HMMM!
See Link
www.youtube.com/watch?v=cya-pBzdcqM&nohtml5=False
History
Thalidomide was created by Grünenthal in 1953 and was used in the late 1950s and early 1960s as a "wonder drug" to treat morning sickness, headaches, coughs, insomnia and colds. Thalidomide was marketed in the UK under the name Distaval in 1958, and advertisements emphasized the drug's complete safety, using phrases such as “non-toxic” and “no known toxicity”.
However, in 1961 an Australian doctor, William McBride, wrote to the Lancet after noticing an increase in deformed babies being born at his hospital – all to mothers who had taken Thalidomide.
Between 1958 and 1962 tens of thousands of women throughout Europe found that the baby they were carrying unaccountably miscarried, or, worse, after they gave birth were told it was stillborn. Thousands more discovered that their babies had severe birth defects, missing arms, legs, or with severe reductions to these limbs, or even worse, damage to their internal organs, brain, heart, kidneys, intestines, genitals, etc. During 1962 record keepers began to count all of the children living who were born damaged by the drug. The only complete records are of those who survived long enough to participate in the national compensation schemes, which were established in Germany, Britain, Japan, Sweden and Australia in the 1970s. The difficulty in uncovering the full toll of the disaster begins with the unknown numbers of miscarriages and stillbirths (possibly up to ten times the number of live births), and the widespread practice of infanticide.
The Thalidomide injuries did not stop once the babies were born. At the age of fifty, the Thalidomide Trust’s records show that around half of all survivors are coping with chronic pain – mainly from muscles and joints (musculo-skeletal pain), largely as a result of the challenges of living with missing or damaged limbs. For many, their bodies are deteriorating far faster than able-bodied people. Several have been told words to the effect “your body is getting the problems of someone in their seventies”, which at forty to fifty years of age is not good news. At least a quarter are coping with developing neurological problems, tingling, numbness, and pain in their affected limbs. This means that a person may be holding a cup, for instance, and the next thing they know is it has fallen to the floor and broken, because of the numbness in their hand. For these survivors, the disaster is still slowly unfolding in their day-to-day lives.
Grünenthal scientists were not only negligent in failing to withdraw the drug when reports of problems came in, or for failing to test it according to the standards of the time, but more than most companies they were very well placed to anticipate the possibility that Thalidomide would cause birth defects.
Grünenthal initially denied claims that the drug hadn’t been extensively tested according to the standards of the time, but once the scandal became undeniable, they sought to deflect blame and limit damage.
In 1961 Thalidomide was eventually withdrawn after being found to be a teratogan - a cause of birth defects. 12 years later, the UK company Distillers Biochemicals Limited (now Diageo) – which was responsible for distributing the drug in the UK – reached a compensation settlement following a legal battle by the families of those affected.
Based on incomplete medical evidence and unrealistic expectations of Thalidomide survivors future needs this settlement has turned out to be at an inadequate level. With all Thalidomide survivors in the UK now over the age of 50, it is no longer sufficient to deal with their rising cost of living, and the dramatic deterioration of their health.
To this day, Grünenthal have never accepted responsibility for the suffering caused by Thalidomide. On September 1st 2012, The Grünenthal Group released a statement containing an apology, stating that it "regrets" the consequences of the drug, which led to babies being born without limbs during the 1950s and 1960s. Although the statement was welcomed by some Thalidomide survivors, it is still not an acceptance of responsibility. They just want to live a comfortable life, and that means Grünenthal should be held accountable and pay for their mistake financially.
Spanish
Historia
La talidomida fue creado por Grünenthal en 1953 y fue utilizado a finales de 1950 y principios de 1960 como una "droga milagrosa" para el tratamiento de las náuseas, dolores de cabeza, tos, insomnio y resfriados. La talidomida fue comercializada en el Reino Unido bajo el nombre Distaval en 1958, y destacó los anuncios de seguridad completa del medicamento, utilizando frases como "no tóxico" y "no hay toxicidad conocida".
Sin embargo, en 1961 un médico australiano, William McBride, escribió a la revista The Lancet después de notar un aumento en los bebés que nacen deformes en su hospital - todo a las madres que habían tomado Talidomida.
Entre 1958 y 1962, decenas de miles de mujeres de toda Europa descubrieron que el bebé que llevaban inexplicablemente abortado, o, peor aún, después de dar a luz se les dijo que estaba muerto. Miles de personas descubrieron que sus bebés nacieron con defectos congénitos graves, los brazos, las piernas, que faltan o con reducciones severas a estos miembros, o peor aún, el daño a sus órganos internos, cerebro, corazón, riñones, intestinos, genitales, etc Durante 1962 guardianes de los registros empezó a contar toda la vida los niños que nacieron dañado por la droga. Los únicos registros completos son de los que sobrevivieron lo suficiente como para participar en los sistemas nacionales de indemnización, que se establecieron en Alemania, Gran Bretaña, Japón, Suecia y Australia en la década de 1970. La dificultad para descubrir el número de víctimas del desastre comienza con los números desconocidos de abortos involuntarios y mortinatos (posiblemente hasta diez veces el número de nacidos vivos), y la práctica generalizada del infanticidio.
Las lesiones de la talidomida no se detuvo una vez que los bebés nacieron. A la edad de cincuenta años, los registros de la confianza talidomida muestran que cerca de la mitad de todos los sobrevivientes están lidiando con el dolor crónico - principalmente de músculos y articulaciones (dolor musculoesquelético), en gran parte como resultado de los desafíos de vivir con la falta o ramas dañadas. Para muchos, sus cuerpos se deterioran mucho más rápido que las personas sanas. Algunos han dicho palabras en el sentido de "su cuerpo está recibiendo los problemas de alguien en los setenta", que a los cuarenta o cincuenta años de edad no es una buena noticia. Al menos una cuarta están lidiando con el desarrollo de problemas neurológicos, hormigueo, entumecimiento y dolor en las extremidades afectadas. Esto significa que una persona puede ser la celebración de una taza, por ejemplo, y lo siguiente que sé es que ha caído al suelo y se rompe, debido a la sensación de adormecimiento en la mano. Para estos sobrevivientes, el desastre está siendo poco a poco se desarrolla en su día a día.
Grünenthal científicos no sólo fueron negligentes al no haber retirado la droga cuando los informes de problemas de vino, o por no probarlo de acuerdo a los estándares de la época, pero más que la mayoría de las empresas que estaban muy bien situados para prever la posibilidad de que la talidomida haría causar defectos de nacimiento.
Grünenthal inicialmente negó las acusaciones de que el medicamento no ha sido ampliamente probado de acuerdo con los estándares de la época, pero una vez que el escándalo se hizo innegable, trataron de desviar la culpa y limitar el daño.
En 1961, la talidomida fue finalmente retirada después de haber sido encontrado para ser un teratogan - una de las causas de los defectos congénitos. 12 años después, el Reino Unido, Distillers Company Limited (ahora Bioquímicos Diageo) - encargada de la distribución de la droga en el Reino Unido - llegó a un acuerdo de compensación después de una batalla legal por las familias de los afectados.
Sobre la base de evidencia incompleta médica y expectativas poco realistas de la talidomida futuro sobrevivientes necesita esta solución ha resultado ser en un nivel adecuado. Con todos los sobrevivientes de la talidomida en el Reino Unido ahora más de 50 años de edad, ya no es suficiente para hacer frente a su creciente costo de vida, y el dramático deterioro de su salud.
A día de hoy, Grünenthal nunca ha aceptado la responsabilidad por el sufrimiento causado por la talidomida. El 1 de septiembre de 2012, el Grupo Grünenthal emitió una declaración que contenga una disculpa, diciendo que "lamenta" las consecuencias de la droga, lo que llevó a los bebés que nacen sin extremidades durante los años 1950 y 1960. Aunque la declaración fue bien recibida por algunos sobrevivientes de la talidomida, no es todavía una aceptación de responsabilidad. Ellos sólo quieren vivir una vida cómoda, y eso quiere decir Grünenthal deben rendir cuentas y pagar por su error financieramente.
Italian
Storia
La talidomide è stato creato da Grünenthal nel 1953 ed è stato utilizzato alla fine del 1950 e 1960 come un "farmaco miracoloso" per curare la malattia di mattina, mal di testa, tosse, insonnia e raffreddori. La talidomide è stato commercializzato nel Regno Unito con il nome di Distaval nel 1958, e la pubblicità ha sottolineato sicurezza del farmaco, con frasi come "non tossico" e "nessuna tossicità conosciuto".
Tuttavia, nel 1961 un medico australiano, William McBride, ha scritto al Lancet dopo aver notato un aumento delle nascite di bimbi malformati essendo nati a suo ospedale - tutti da madri che avevano assunto talidomide.
Tra il 1958 e il 1962 decine di migliaia di donne in tutta Europa ha scoperto che il bambino che portavano inspiegabilmente abortito, o, peggio, dopo che ha dato alla luce hanno detto che era morto. Altre migliaia hanno scoperto che i loro bambini hanno gravi difetti di nascita, braccia, gambe, mancanti o con gravi riduzioni a queste arti, o peggio ancora, danni ai loro organi interni, cervello, cuore, reni, intestino, genitali, ecc Nel 1962 custodi record cominciò a contare tutta la vita i bambini che sono nati danneggiati dal farmaco. Le uniche registrazioni complete sono di coloro che sono sopravvissuti abbastanza a lungo per partecipare ai sistemi di indennizzo nazionali, che sono stati stabiliti in Germania, Gran Bretagna, Giappone, Svezia e Australia nel 1970. La difficoltà nello scoprire il bilancio del disastro inizia con i numeri sconosciuti di aborti spontanei e nati morti (forse fino a dieci volte il numero di nati vivi), e la pratica diffusa di infanticidio.
Le lesioni Talidomide non si è fermata una volta che i bambini sono nati. All'età di 50, del Trust talidomide i tabulati mostrano che circa la metà di tutti i sopravvissuti stanno affrontando con dolore cronico - principalmente da muscoli e le articolazioni (il dolore muscoloscheletrico), soprattutto a causa delle sfide della vita con mancanti o arti danneggiati. Per molti, i loro corpi si stanno deteriorando molto più veloce di persone abili. Molti hanno detto parole per l'effetto "il tuo corpo è sempre il problema di qualcuno nei loro anni settanta", che a 40-50 anni di età non è una buona notizia. Almeno un quarto stanno affrontando con lo sviluppo di problemi neurologici, formicolio, intorpidimento e dolore a carico degli arti colpiti. Ciò significa che una persona può essere in possesso di un tazza, per esempio, e la prossima cosa che so è che è caduto a terra e rotto, a causa del torpore in mano. Per questi sopravvissuti, il disastro è ancora lentamente svolgendo nel loro giorno per giorno la vita.
Grünenthal scienziati non erano solo negligenza nel non ritirare il farmaco quando i report di problemi è venuto in, o per non aver testarlo secondo gli standard del tempo, ma più che la maggior parte delle aziende erano molto ben disposti ad anticipare la possibilità che Thalidomide avrebbe causare difetti di nascita.
Grünenthal inizialmente smentito che il farmaco non era stato ampiamente testati secondo gli standard del tempo, ma una volta che lo scandalo è diventata innegabile, hanno cercato di deviare la colpa e di limitare i danni.
Nel 1961 talidomide è stata infine ritirata dopo essere stato trovato per essere un teratogan - una causa di difetti di nascita. 12 anni dopo, i Distillers Company Limited, Regno Unito Biochemicals (ora Diageo) - incaricata di distribuire il farmaco nel Regno Unito - ha raggiunto un accordo di compensazione a seguito di una battaglia legale da parte delle famiglie delle persone colpite.
Sulla base di prove mediche incomplete e le aspettative non realistiche del futuro Thalidomide sopravvissuti ha bisogno di questa soluzione si è rivelata essere ad un livello insufficiente. Con tutti i sopravvissuti Talidomide nel Regno Unito ora di età superiore ai 50 anni, non è più sufficiente per affrontare la loro crescente costo della vita, e il drammatico deterioramento della loro salute.
Fino ad oggi, la Grünenthal non hanno mai accettato la responsabilità per la sofferenza causata dal talidomide. Il 1 ° settembre 2012, il Gruppo Grünenthal ha rilasciato una dichiarazione che contiene delle scuse, affermando che esso "deplora" le conseguenze della droga, che ha portato a bambini nati senza arti nel corso del 1950 e 1960. Anche se la dichiarazione è stata accolta da alcuni sopravvissuti talidomide, non è ancora una assunzione di responsabilità. Vogliono solo vivere una vita comoda, e questo significa che Grünenthal dovrebbero essere ritenuti responsabili e pagare per il loro errore finanziario.
More History
www.flickr.com/photos/duckwalk/sets/72157615944260359/
The Federal Dominion Public Building at 269 Main Street.
Construction was financed under the City of Winnipeg’s unemployment relief program of 1932 and Canada’s Public Works Construction Act of 1934.
Together, this cooperation of federal and municipal funding helped create one of the largest buildings constructed in Canada during the Great Depression era.
The Federal Building is based on the architectural designs of George William Northwood (under the direction of T. W. Fuller, Chief Architect of the Public Works Department), and awarded to the local contractor firm of Carter-Halls-Aldinger at a tendered bid of $1,412,229.
The seven-storey building consisted of a steel frame covered with Tyndall-stone with concrete caissons and concrete floors.
Design of the exterior main floor was Norman influenced, with the upper floors in Gothic styling.
The construction project served as relief work for some 1,300 labourers. The exterior was largely completed by December 1935, with the interior work continuing into 1936.
Upon completion, the facility housed federal government offices that were previously spread around the city. The building was ready for occupancy in June 1936.
The Federal Building was classified Federal Heritage Building 11 October, 1990.
Created with ChatGPT
Prompt - Create a 16:9 Ethereal ghostly woman floating above cracked stone steps of an ancient gothic mansion, long wet white hair partially obscuring a sorrowful face, hollow luminous eyes and pale translucent skin, wearing a tattered flowing gown of shredded gauze and silk that billows like mist and threads into the fog, delicate outstretched hands with elongated fingers, ravens circling in a stormy sky, drifting embers and ash, dense volumetric fog curling around ruined columns and ornate decaying stone architecture with climbing ivy, dramatic cinematic backlight and rim light creating high contrast chiaroscuro, desaturated cold tones with warm ember highlights, ultra‑detailed textures on fabric, skin and weathered stone, intricate floating fabric strands, motion blur at gown edges, razor‑sharp facial and microdetail, deep atmospheric depth, low angle symmetrical composition, subtle film grain, photorealistic fantasy mood, haunting, majestic, cinematic atmosphere... 64k quality
Pic and prompt by Adrian
Monster High
Create-A-Monster
Vampire
I thought he was a little dorky (the wig was a bit of a challenge so I'm hoping you hair stylistas out there who do manage to get him do something fun with it) but nonetheless he's cute. He'll be my 'Justin Biter' = cute, not too sexy, non-threatening and full of swag.
Creating the Future: Policy & Social Change
L-R:
Terri Austin — Global Head of Diversity, McGraw-Hill Financial
Patricia Lobaccaro — CEO, Brazil Foundation
Yasmine Ergas — Associate Director, Institute for the Study of Human Rights; Director, Gender and Public Policy Specialization, Columbia University
Michele Wucker — President, World Policy Institute
5th Annual Womensphere Emerging Leaders Global Summit 2014
THE NEXT GENERATION OF WOMEN LEADERS & INNOVATORS CREATING THE FUTURE
Main Summit Day - January 15,2014 @ Columbia University
Immersion & Exploration Days - January 14 and January 16 @ Multiple Venues in New York City
(Credit Suisse, BBDO, New York Stock Exchange, Diane von Furstenberg, Tutor.com/IAC, Yahoo, Paley Center for Media, CNN)
*** Join in & continue the conversation:
#WomensphereSummit and #EmergingLeaders and #CreateOurFuture
Twitter: @womensphere @analisabalares
Partner Twitter: @accenture @mfhi @americanair @nielsen @siegelgale @scholastic @goldmansachs @eynews @hudsonhotels @Columbia @CUSEAS
Academic Delegations: @Columbia @CUSEAS @MIT @McMasterU @mountholyoke @citytechnews @nyuniversity @wakeforest1834 @yale
Summit Website:
womensphere.org/emergingleadersglobalsummit2014/
Organization Websites:
Like us on Facebook: